Indian Journal of Critical Care Case Report

Register      Login

VOLUME 2 , ISSUE 5 ( September-October, 2023 ) > List of Articles

CASE REPORT

Noncirrhotic Multifactorial Hyperammonemia: Unmasking an Adult-onset Partial Urea Cycle Disorder

Rupak Banerjee, Paramita Basu, Samyogita Choudhary, Chandrashish Chakravarty

Keywords : Case report, Cerebral edema, Continuous renal replacement therapy, Noncirrhotic hyperammonemic encephalopathy, Status epilepticus, Urea cycle disorder

Citation Information : Banerjee R, Basu P, Choudhary S, Chakravarty C. Noncirrhotic Multifactorial Hyperammonemia: Unmasking an Adult-onset Partial Urea Cycle Disorder. 2023; 2 (5):145-147.

DOI: 10.5005/jp-journals-11006-0075

License: CC BY-NC 4.0

Published Online: 27-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Aim and background: Urea cycle disorder (UCD) is a metabolic disturbance and can be a harbinger of life-threatening hyperammonemic encephalopathy. We report a case of adult-onset partial urea cycle defect precipitated by septic shock and status epilepticus and its successful treatment with continuous renal replacement therapy, adaptive nutrition, nitrogen scavengers, and gut decontamination. Case description: A 37-year-old woman with known seizure disorder presented with status epilepticus, urosepsis, and septic shock due to Enterococcus faecalis infection. Her two other sisters died from an unknown neuropsychiatric illness in early childhood. She was initially treated with invasive mechanical ventilation, vasopressor support, intravenous antibiotics, and antiepileptic drugs. After stabilization of hemodynamics and control of visible seizures, her mental status was not improving despite the sedation hold. Further workup revealed high ammonia, respiratory alkalosis, triphasic waveform on the electroencephalogram, normal liver function and sonologic evidence of cerebral edema. Urinary analysis for amino acids and organic acids was noncontributory. A partial defect in the urea cycle was suspected and she was successfully treated with continuous renal replacement therapy and other available adjunctive treatments to a favorable outcome. Conclusion: In patients who present with noncirrhotic hyperammonemic encephalopathy and have had one or multiple stressors, a diagnosis of UCD should be suspected to optimize early management and improve prognosis.


HTML PDF Share
  1. Enns GM, Berry SA, Berry GT, et al. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 2007;356(22):2282–2292. DOI: 10.1056/NEJMoa066596
  2. Summar M, Tuchman M. Proceedings of a consensus conference for the management of patients with urea cycle disorders. J Pediatr 2001;138(1 Suppl):S6–10. DOI: 10.1067/mpd.2001.111831
  3. Machado MC, Pinheiro da Silva F. Hyperammonemia due to urea cycle disorders: a potentially fatal condition in the intensive care setting. J Intensive Care 2014;2(1):22. DOI: 10.1186/2052-0492-2-22
  4. Msall M, Batshaw ML, Suss R, et al. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 1984;310(23):1500–1505. DOI: 10.1056/NEJM198406073102304
  5. Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 1998;21(Suppl 1):151–159. DOI: 10.1023/a:1005374027693
  6. Nicolaides P, Liebsch D, Dale N, et al. Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch Dis Child 2002;86(1):54–56. DOI: 10.1136/adc.86.1.54
  7. Wong KY, Wong SN, Lam SY, et al. Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 1998;12(7):589–591. DOI: 10.1007/s004670050511
  8. Wiegand C, Thompson T, Bock GH, et al. The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 1980;96(1):142–144. DOI: 10.1016/s0022-3476(80)80352-0
  9. McBryde KD, Kershaw DB, Bunchman TE, et al. Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 2006;148(6):770–778. DOI: 10.1016/j.jpeds.2006.01.004
  10. Batshaw ML, MacArthur RB, Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 2001;138(1 Suppl):S46–S55. DOI: 10.1067/mpd.2001.111836
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.